[Chevychelov]

CHAMPION PCI and CHAMPION PLATFORM
Among patients undergoing PCI for a variety of indications in the CHAMPION PCI and CHAMPION PLATFORM trials, the use of intravenous cangrelor was not superior to clopidogrel 600 mg, either started before or after the procedure
[Ссылки доступны только зарегистрированным пользователям ]

ACC Launches CV Practice Network
Cardiovascular practices face myriad challenges in today's health care environment — legislative and regulatory threats to payment, demands to demonstrate performance and justify clinical decisions, the emergence of reimbursement models based on efficiency or value, and the rise of new and untested business arrangements. To address these challenges, the ACC last month launched the PINNACLE Network™
[Ссылки доступны только зарегистрированным пользователям ]

PLATO: Treatment with ticagrelor reduces CV death, MI, and stroke in STEMI patients.
[Ссылки доступны только зарегистрированным пользователям ]

NCDR® Presents 14 Abstracts at AHA : The American Heart Association accepted 14 NCDR abstracts for presentation at the Annual Scientific Sessions.
[Ссылки доступны только зарегистрированным пользователям ]

POPULAR: In patients undergoing elective PCI, several platelet function tests can help predict one-year thrombosis but not bleeding events.
[Ссылки доступны только зарегистрированным пользователям ]